Vifor Pharma shares are likely to be delisted from the Swiss stock exchange soon. Very few shareholders will mourn the company. Whether the new owner CSL can revive the business is questionable.
The headquarters of the Swiss drug manufacturer Vifor Pharma in Glattbrugg.
Many people feast on large takeovers: consultants, lawyers and investment bankers earn lavish fees from them, as is also shown by the takeover of the Swiss drug manufacturer Vifor Pharma by its Australian competitor CSL.